Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Mark A. Belsey"'
Publikováno v:
Neurochemical Research. 32:1940-1949
Cell swelling is associated with the activation of an increase in the osmosensitive taurine release (OTR) rate, which serves to decrease cell volume as part of a process known as regulatory volume decrease. OTR, which is sensitive to many pharmacolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aafb9bab4ae440921e478ca9d35c2bed
https://doi.org/10.1007/s11064-007-9389-7
https://doi.org/10.1007/s11064-007-9389-7
Increased uptake of biologics in historically small molecule blockbuster-dominated therapeutic areas
Autor:
Mark J. Belsey, Duncan Emerton
Publikováno v:
Journal of Commercial Biotechnology. 13:48-51
The two leading therapeutic areas for biologic products, in terms of current sales and pipeline focus, are oncology and AIID (arthritis, immune and inflammatory disorders). Datamonitor has recently analysed these markets. 1, 2 Biologics designed to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6015a81aefa4ea303f5fcd0999004b0e
https://doi.org/10.1057/palgrave.jcb.3050034
https://doi.org/10.1057/palgrave.jcb.3050034
Publikováno v:
Journal of Commercial Biotechnology. 12:150-155
Following flu vaccine manufacturing and supply issues in the USA and the global threat of an avian flu pandemic, the flu market is attracting considerable interest. This market was worth approximately US$1.1bn in 2004, and it is expected to grow to U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d64328ec1e96d58f82f789cf8f23cac2
https://doi.org/10.1057/palgrave.jcb.3040160
https://doi.org/10.1057/palgrave.jcb.3040160
Autor:
John Savopoulos, Mark J. Belsey
Publikováno v:
Journal of Medical Marketing. 6:6-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::044a9328d0a387994fd8b8f40cb86732
https://doi.org/10.1057/palgrave.jmm.5040262
https://doi.org/10.1057/palgrave.jmm.5040262
Autor:
Mark J. Belsey, Alex K Pavlou
Publikováno v:
Journal of Commercial Biotechnology. 11:369-373
As part of Datamonitor's alliance and licensing strategic analysis, the authors have completed a two year survey of the trends underlying early-stage drug discovery and development collaborations between October 2002 and September 2004, which include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b446a811a4d89c960cb711ad36b375
https://doi.org/10.1057/palgrave.jcb.3040139
https://doi.org/10.1057/palgrave.jcb.3040139
Autor:
Alex K Pavlou, Mark J. Belsey
Publikováno v:
Journal of Commercial Biotechnology. 11:275-278
The DNA/RNA market is currently at an early stage of development, with only two marketed products that together generated an estimated US$30m in 2004. The launch of Pfizer/Eyetech's ophthalmological aptamer Macugen (pegaptanib) is set to help power m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ead2e4386c76536a5e9e2bafc5760688
https://doi.org/10.1057/palgrave.jcb.3040127
https://doi.org/10.1057/palgrave.jcb.3040127
Autor:
Alex K Pavlou, Mark J. Belsey
Publikováno v:
Journal of Commercial Biotechnology. 11:171-175
Datamonitor analysis has identified two key company categories currently shaping the biotech industry: the leading biotherapeutics players and the emerging biotherapeutics players. Analysis of financial trends of companies in these categories from 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09f903f753bb79b307654dbff8f0c895
https://doi.org/10.1057/palgrave.jcb.3040114
https://doi.org/10.1057/palgrave.jcb.3040114
Publikováno v:
Annals of the New York Academy of Sciences. 1028:38-55
Key elements of tumor development include proliferation, migration, invasiveness, and angiogenesis. Activation of the volume-sensitive organic osmolyte/anion channel (VSOAC) has been suggested to play a role in all of these processes. VSOACs may ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a335fa5d6b498f0583b828919b4c25d5
https://doi.org/10.1196/annals.1322.004
https://doi.org/10.1196/annals.1322.004
Autor:
Alex K Pavlou, Mark J. Belsey
Publikováno v:
Journal of Commercial Biotechnology. 11:80-86
Datamonitor analysis recognises 18 biological brands that are expected to drive sales within the biopharma sector. The group includes 12 recombinant DNA proteins and six antibodies which are forecast to generate sales of US$29.0bn and US$13.2bn by 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2534f99ca18904cbe306f4cdad70bd75
https://doi.org/10.1057/palgrave.jcb.3040104
https://doi.org/10.1057/palgrave.jcb.3040104
Publikováno v:
European Journal of Pharmacology. 474:185-193
FACS analysis and [14C]-taurine efflux were used to determine whether activation of the volume-sensitive organic osmolyte/anion channel plays a role in cell cycle progression. This was achieved by examining the effects of a collection of (i) H(1) ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34ceaec1c2b2739bda25dd114b8eeb26
https://doi.org/10.1016/s0014-2999(03)02073-9
https://doi.org/10.1016/s0014-2999(03)02073-9